Comparison of TFII‐I gene family members deleted in Williams‐Beuren syndrome

Williams‐Beuren syndrome (WBS) is a neurological disorder resulting from a microdeletion, typically 1.5 megabases in size, at 7q11.23. Atypical patients implicate genes at the telomeric end of this multigene deletion as the main candidates for the pathology of WBS in particular the unequal cognitive profile associated with the condition. We recently identified a gene (GTF2IRD2) that shares homology with other members of a unique family of transcription factors (TFII‐I family), which reside in the critical telomeric region. Using bioinformatics tools this study focuses on the detailed assessment of this gene family, concentrating on their characteristic structural components such as the leucine zipper (LZ) and I‐repeat elements, in an attempt to identify features that could aid functional predictions. Phylogenetic analysis identified distinct I‐repeat clades shared between family members. Linking functional data to one such clade has implicated them in DNA binding. The identification of PEST, synergy control motifs, and sumoylation sites common to all family members suggest a shared mechanism regulating the stability and transcriptional activity of these factors. In addition, the identification/isolation of short truncated isoforms for each TFII‐I family member implies a mode of self‐regulation. The exceptionally high identity shared between GTF2I and GTF2IRD2, suggests that heterodimers as well as homodimers are possible, and indicates overlapping functions between their respective short isoforms. Such cross‐reactivity between GTF2I and GTF2IRD2 short isoforms might have been the evolutionary driving force for the 7q11.23 chromosomal rearrangement not present in the syntenic region in mice.

[1]  Colleen A. Morris,et al.  The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis , 1993, Cell.

[2]  C. Vinson,et al.  Classification of Human B-ZIP Proteins Based on Dimerization Properties , 2002, Molecular and Cellular Biology.

[3]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[4]  J. Thornton,et al.  Influence of proline residues on protein conformation. , 1991, Journal of molecular biology.

[5]  A. Karmiloff-Smith,et al.  Williams syndrome: use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes. , 1999, American journal of human genetics.

[6]  A. Buonanno,et al.  Characterization of General Transcription Factor 3, a Transcription Factor Involved in Slow Muscle-specific Gene Expression* , 2003, The Journal of Biological Chemistry.

[7]  A. Schinzel,et al.  High level of unequal meiotic crossovers at the origin of the 22q11. 2 and 7q11.23 deletions. , 1998, Human molecular genetics.

[8]  Stephen J. Palmer,et al.  hMusTRD1α1 Represses MEF2 Activation of the Troponin I Slow Enhancer* , 2003, Journal of Biological Chemistry.

[9]  A. Roy,et al.  TFII-I Regulates Vβ Promoter Activity through an Initiator Element , 1998, Molecular and Cellular Biology.

[10]  B. Cochran,et al.  TFII-I Enhances Activation of the c-fosPromoter through Interactions with Upstream Elements , 1998, Molecular and Cellular Biology.

[11]  L R Osborne,et al.  Williams-Beuren syndrome: unraveling the mysteries of a microdeletion disorder. , 1999, Molecular genetics and metabolism.

[12]  P. Sharp,et al.  Regulation of Immunoglobulin Promoter Activity by TFII-I Class Transcription Factors* , 2004, Journal of Biological Chemistry.

[13]  S. Rogers,et al.  PEST sequences and regulation by proteolysis. , 1996, Trends in biochemical sciences.

[14]  Stephen W. Scherer,et al.  A 1.5 million–base pair inversion polymorphism in families with Williams-Beuren syndrome , 2001, Nature Genetics.

[15]  W. Yule,et al.  A cognitive and behavioural phenotype in Williams syndrome. , 1991, Journal of clinical and experimental neuropsychology.

[16]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[17]  M. Tassabehji,et al.  Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams–Beuren syndrome , 2004, European Journal of Human Genetics.

[18]  R. Roeder,et al.  Cloning of an Inr‐ and E‐box‐binding protein, TFII‐I, that interacts physically and functionally with USF1 , 1997, The EMBO journal.

[19]  J. Denie,et al.  Supravalvular Aortic Stenosis , 1958, Circulation.

[20]  S. H. Baek,et al.  Versatile protein tag, SUMO: Its enzymology and biological function , 2002, Journal of cellular physiology.

[21]  G. Nolan,et al.  NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Cochran,et al.  JAK2 Activates TFII-I and Regulates Its Interaction with Extracellular Signal-Regulated Kinase , 2001, Molecular and Cellular Biology.

[23]  A. Karmiloff-Smith,et al.  Williams syndrome: from genotype through to the cognitive phenotype. , 2000, American journal of medical genetics.

[24]  A. Roy,et al.  c-Src-dependent Transcriptional Activation of TFII-I* , 2002, The Journal of Biological Chemistry.

[25]  F. Ruddle,et al.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxβ , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Roeder,et al.  An alternative pathway for transcription initiation involving TFII-I , 1993, Nature.

[27]  Patricia Spallone,et al.  Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome , 1993, Nature Genetics.

[28]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[29]  F. Ruddle,et al.  Repression of TFII-I-dependent transcription by nuclear exclusion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  U. Francke.  Williams-Beuren syndrome: genes and mechanisms. , 1999, Human molecular genetics.

[31]  D T Jones,et al.  Protein secondary structure prediction based on position-specific scoring matrices. , 1999, Journal of molecular biology.

[32]  A. Roy,et al.  Alternatively Spliced Isoforms of TFII-I , 2000, The Journal of Biological Chemistry.

[33]  Rumiko Matsuoka,et al.  Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on Chromosome 7q11.23 , 2003, Genetics in Medicine.

[34]  M. Leppert,et al.  A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A Mari,et al.  Detection of an atypical 7q11.23 deletion in Williams syndrome patients which does not include the STX1A and FZD3 genes , 1999, Journal of medical genetics.

[36]  A. Beuren,et al.  Supravalvular Aortic Stenosis in Association with Mental Retardation and a Certain Facial Appearance , 1962, Circulation.

[37]  S. Desiderio,et al.  cGMP-dependent Protein Kinase Iβ Physically and Functionally Interacts with the Transcriptional Regulator TFII-I* , 2002, The Journal of Biological Chemistry.

[38]  F. Melchior,et al.  SUMO: ligases, isopeptidases and nuclear pores. , 2003, Trends in biochemical sciences.

[39]  F. Ruddle,et al.  Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region. , 2002, Genomics.

[40]  P. Stankiewicz,et al.  Molecular-evolutionary mechanisms for genomic disorders. , 2002, Current opinion in genetics & development.

[41]  D. Grueneberg,et al.  A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: identity to TFII-I. , 1997, Genes & development.

[42]  U. Francke,et al.  Molecular definition of the chromosome 7 deletion in Williams syndrome and parent-of-origin effects on growth. , 1996, American journal of human genetics.

[43]  U. Francke,et al.  A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK. , 1998, Human molecular genetics.

[44]  R. Borgatti,et al.  Unusual cognitive and behavioural profile in a Williams syndrome patient with atypical 7q11.23 deletion , 2003, Journal of medical genetics.

[45]  R. Roeder,et al.  Direct role for Myc in transcription initiation mediated by interactions with TFII-I , 1993, Nature.

[46]  Ursula Bellugi,et al.  I. The Neurocognitive Profile of Williams Syndrome: A Complex Pattern of Strengths and Weaknesses , 2000, Journal of Cognitive Neuroscience.

[47]  J. Posakony,et al.  extramacrochaetae, a negative regulator of sensory organ development in Drosophila, defines a new class of helix-loop-helix proteins , 1990, Cell.

[48]  A. Dejean,et al.  Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.

[49]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[50]  A. Schinzel,et al.  Unequal interchromosomal rearrangements may result in elastin gene deletions causing the Williams-Beuren syndrome. , 1996, Human molecular genetics.

[51]  A. Roy,et al.  Structure-Function Analysis of TFII-I , 2001, The Journal of Biological Chemistry.

[52]  C. J. Sells,et al.  The williams elfin facies syndrome: the psychological profile as an aid in syndrome identification. , 1978, Pediatrics.

[53]  X. Yan,et al.  Characterization and gene structure of a novel retinoblastoma-protein-associated protein similar to the transcription regulator TFII-I. , 2000, The Biochemical journal.

[54]  Stephen K. Burley,et al.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.

[55]  Rumiko Matsuoka,et al.  VI. Genome Structure and Cognitive Map of Williams Syndrome , 2000, Journal of Cognitive Neuroscience.

[56]  W. Robinson,et al.  Delineation of 7q11.2 deletions associated with Williams-Beuren syndrome and mapping of a repetitive sequence to within and to either side of the common deletion. , 1996, Genomics.

[57]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[58]  J. Iñiguez-Lluhí,et al.  A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.

[59]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[60]  A. Roy,et al.  Identification of TFII-I as the Endoplasmic Reticulum Stress Response Element Binding Factor ERSF: Its Autoregulation by Stress and Interaction with ATF6 , 2001, Molecular and Cellular Biology.

[61]  A. Roy.  Biochemistry and biology of the inducible multifunctional transcription factor TFII-I. , 2001, Gene.

[62]  R. Adolphs,et al.  II. Hypersociability in Williams Syndrome , 2000, Journal of Cognitive Neuroscience.

[63]  J. Lupski.  Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. , 1998, Trends in genetics : TIG.

[64]  R. Roeder,et al.  Cooperative interaction of an initiator-binding transcription initiation factor and the helix–loop–helix activator USF , 1991, Nature.

[65]  S. Scherer,et al.  PMS2-related genes flank the rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7. , 1997, Genomics.

[66]  J. Iñiguez-Lluhí,et al.  A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3* , 2003, The Journal of Biological Chemistry.

[67]  S. Pillai,et al.  Regulation of Nuclear Localization and Transcriptional Activity of TFII-I by Bruton’s Tyrosine Kinase , 1999, Molecular and Cellular Biology.

[68]  C A Morris,et al.  Natural history of Williams syndrome: physical characteristics. , 1988, The Journal of pediatrics.